When was Oribiotech founded?

Oribiotech was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Oribiotech located?

Oribiotech is headquartered in London, United Kingdom.

Who is the current CEO of Oribiotech?

Jason C Foster of Oribiotech. They are also angel investors in 2 startups.

Which legal entities is Oribiotech associated with?

Oribiotech is associated with Oribiotech Ltd.

How many employees does Oribiotech have?

As of Mar 31, 2026, the latest employee count at Oribiotech is 87.

Is Oribiotech a funded company?

Oribiotech is a funded company, having raised a total of $281M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 09, 2016.

How much is Oribiotech worth?

The latest valuation of Oribiotech is £***** as of Jun 22, 2022.

When was the latest funding round of Oribiotech?

Oribiotech's latest funding was a $***** Series B round on Jun 22, 2022, with participation from 0 investor.

What is the annual revenue of Oribiotech?

Annual revenue of Oribiotech is £474K as on Dec 31, 2024.

Where does Oribiotech rank among its competitors?

Oribiotech ranks 1st amongst 21 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Cellular Origins, which secured $40M in Dec, 2025.

Who are the top competitors of Oribiotech?

Oribiotech's top competitors include Multiply Labs, Cellular Origins and Celltrio. Among them, Cellular Origins secured the most recent funding round in December, 2025.

Oribiotech - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool. The technology integrates bioreactor systems and sterile connection tools to facilitate the manufacturing of biological products. The equipment supports process control and scalability throughout the development cycle, from research stages to commercial production. The system design aims to improve reproducibility and throughput in the creation of therapeutic materials.

Website: oribiotech.com
Social
Email ID: *****@oribiotech.com

Key Metrics

Founded Year

2015

Location

London, United Kingdom

Stage

Series B

Total Funding

$281M in 6 rounds

Latest Funding Round

Series B, Jun 22, 2022, $*****

Post Money Valuation

£***** as on Jun 22, 2022

Investors

Amadeus Capital & 21 more

Ranked

1^st among 21 active competitors

Annual Revenue

£474K as on Dec 31, 2024

Employee Count

87 as on Mar 31, 2026

Similar Companies

Multiply Labs & 19 more

View Oribiotech's full profile

Oribiotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Oribiotech Ltd CIN: 9757696 , United Kingdom, Active	Sep 01, 2015	$606K (As on Dec 31, 2024)	52 (As on Dec 31, 2024)

Oribiotech has raised a total funding of $281M over 6 rounds. Its first funding round was on Nov 09, 2016. Oribiotech has 10 institutional investors and 12 angel investors.

Here is the list of recent funding rounds of Oribiotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 22, 2022	4386319	Series B	1141577	6866139	3789038	2373989
Jan 05, 2022	4215868	Series B	8887793	3104990	2633261	Puhua Capital & 5 more
Sep 07, 2020	3819261	Series A	1799535	4630774	Northpond Ventures & 1 more	Amadeus Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Oribiotech's funding rounds and investors

The founders of Oribiotech are Chris Mason and Farlan Veraitch. Jason C Foster is the CEO of Oribiotech.

Here are the details of Oribiotech's key team members:

Chris Mason: Co-Founder of Oribiotech and founder of 1 other company. They serve on the board of 1 company.
Farlan Veraitch: Co-Founder & Chief Scientific Officer of Oribiotech. They serve on the board of 1 company.
Contact Info: 1 email address
Jason C Foster: CEO of Oribiotech. They are also an angel investor in 2 startups and serve on the board of 1 company.
Contact Info: 1 email address

Oribiotech's Board of Directors

Oribiotech's board has 10 active members. Chris Mason, Farlan Veraitch and Jason C Foster are part of team and Barry Clare, Pierre Robert Socha, Jonathan Russell Hay, Adam Joseph Wieschhaus, Annalisa Mary Jenkins, Paul Matthew Meister and Andrea Liapis Jackson are independent board members.

Here is the list of Oribiotech's board of directors:

Name	Type	Representing	Status	Duration
Farlan Veraitch	Team	-	Current	10y 8m
Jason C Foster	Team	-	Current	6y 9m
semzvty	Team	-	Past	1y 5m
stsrpmo	Investor	-	Past	9y 9m
Barry Clare	Independent board member	-	Current	6y 9m
pz{muqk	Independent board member	-	Current	4y 9m
kdxuuip	Independent board member	-	Current	7y 3m
cngbijv	Independent board member	-	Current	7y 3m
ylcfirf	Independent board member	-	Current	1y 6m
kzmvdrf	Independent board member	-	Current	8y 5m
bcxmycd	Independent board member	-	Current	5y 1m
dm{aoho	Independent board member	-	Past	2y 4m
ebameej	Independent board member	-	Past	5y 4m

View details of Oribiotech's Founder profiles and Board Members

Oribiotech's employee count trend

Oribiotech has 87 employees as of Mar 26. Here is Oribiotech's employee count trend over the years:

Uncover Oribiotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oribiotech include Multiply Labs, Cellular Origins and Celltrio. Here is the list of Top 10 competitors of Oribiotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Chimera, Novalis LifeSciences & 20 others	66/100
2nd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Zillionize, Casdin Capital & 22 others	63/100
3rd	Cellular Origins 2021, Cambridge (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	52/100
4th	Celltrio 2018, Santa Clara (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	45/100
5th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	42/100
6th	Unicorn Biotechnologies 2020, Cambridge (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Acequia Capital, HAX & 9 others	41/100
7th	Curiosis 2015, South Korea, Public	Developer of automation technologies for life science research laboratories	-	Knet Investment Partners, Alpen Route	41/100
8th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 3 others	40/100
9th	Iorgan 2024, Chapel Hill (United States), Seed	Developer of a platform for AI-guided cell manufacturing and development	$2M	First Star Ventures, Terasaki & 4 others	30/100
10th	Guangdong Bogong Medical Technology 2022, Dongguan (China), Series A	Developer of robotic solution for life science research	-	Lime Capital, Endeavor Fund	30/100